• / Free eNewsletters & Magazine
  • / My Account
Home>Authors>Julie Stralow

Julie Stralow

  1. All
  2. Morningstar Articles
  3. Videos
  4. Investing
  1. How Health-Care Reform Will Affect Device Makers

    Device firms are going to plan accordingly and try to control their costs ahead of a planned 2013 device tax, says Morningstar analyst Julie Stralow .

  2. Credit Outlook: Sector Updates and Top Bond Picks

    Get our sector-by-sector take on the bond market, plus our five best bond ideas.

  3. What the Heck Is Robotic Surgery?

    Morningstar OptionInvestor editor Erik Kobayashi-Solomon and senior health-care analyst Julie Stralow discuss Intuitive Surgical's appeal and outlook.

  4. One Bond, Two Stock Ideas in Devices

    Morningstar's Julie Stralow sees opportunities in both the debt and equity of medical device firms Stryker and Zimmer.

  5. How Will M&A Affect Pharma Balance Sheets?

    Even if a potential Sanofi/Genzyme deal foretells a wave of consolidation, investors shouldn't worry about big pharma credit quality, says Morningstar's Julie Stralow .

  6. Credit Outlook: Sector Updates and Top Bond Picks

    Get our sector-by-sector take on the bond markets, plus our five best bond ideas.

  7. Smith & Nephew: Innovation, Education Key to Emerging Market

    Medical-device expansion in the BRIC countries will accelerate as price points are lowered and more doctors learn how to use orthopedics, says Smith & Nephew's Phil Cowdy.

  8. Will Reform Weigh on Medical Device Firms?

    If long-term investors can see beyond reform uncertainty, they could make a great return on Stryker shares.

  9. How Our Credit Ratings Have Performed

    Morningstar's Brian Nelson reviews the performance of our corporate credit ratings on their one-year anniversary of their launch, plus two health-care bond picks.

  10. Four Corporate Bond Picks With Upside Potential

    Morningstar's credit research team makes the case for health care, retail, and racetrack credits.

12
Upcoming Events
Conferences
Webinars

©2012 Morningstar Advisor. All right reserved.